What is Qelbree?

Qelbree is a once-a-day ADHD medication for children aged 6-17 years. In clinical trials, Qelbree has been proven to help reduce ADHD symptoms, with manageable side effects when taken as directed.

Once-a-day treatment  

Dosing options ▼

Non-stimulant therapy benefits ▼

Qelbree is a once-a-day treatment for ADHD

Qelbree can easily fit into your and your child’s schedule.

Maintaining regular treatment with Qelbree, as directed, can lead to more consistent ADHD symptom control for your child.

Full-day coverage

Qelbree uses 2-bead Microtrol® Technology for rapid and extended release, providing reliable medication coverage throughout the day

A convenient treatment schedule

Qelbree is taken once a day, and is easy to use

The focus to help make the routine

unforgettable

Once-a-day treatment  

Dosing options  

Non-stimulant therapy benefits  

3 strengths offer tailored dosing for your child

Qelbree™ (viloxazine extended-release capsules) Dosing Options

The recommended starting dose for children 6-11 years old is 100 mg once daily, and 200 mg once daily for those 12-17 years old. Your child’s doctor may gradually increase their dose over 1-3 weeks until they reach the dose that’s right for them. This process is called titration.

The maximum recommended dosage for children 6-17 years old is 400 mg once daily.

Two ways to take Qelbree

The Qelbree capsule can be swallowed whole, or the capsule can be opened and its entire contents sprinkled onto a spoonful of applesauce or pudding.† Do not cut, crush, or chew the capsules.

Qelbree is the only non-stimulant ADHD treatment that can be sprinkled on food for easier dosing for patients who are unable to swallow capsules.

†Once added to the applesauce, Qelbree should be all consumed, without chewing, within two hours. Once added to pudding, Qelbree should be all consumed, without chewing, within 15 minutes. Do not store for future use.

Another kind of ADHD treatment

Learn more about non-stimulant Qelbree, when to expect results, and why it could be right for your child.

Get started 

The benefits of a non-stimulant therapy

Once-a-day treatment  

Dosing options  

Non-stimulant therapy benefits  

As a non-stimulant, Qelbree

  •  Has no evidence of abuse or misuse
  •  Can be conveniently refilled without the need for new prescriptions every month
  •  Is proven to be safe*, with manageable side effects
  •  Is unlikely to have any negative interactions with stimulants like methylphenidate and amphetamine

Talk with your child's doctor about all medications they take, and see if Qelbree is right for your child.

*Important: Monitor your child for mood or behavior changes. Your child’s doctor should also monitor for changes in blood pressure and heart rate.

A change you can see

Qelbree is the first non-stimulant approved for ADHD in over a decade.

See the results  

IMPORTANT SAFETY INFORMATION ABOUT QELBREE

INDICATION

Qelbree® (viloxazine extended-release capsules) is a prescription medicine used to treat ADHD in adults and children 6 years and older.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment [read more] or when the dose is changed. Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment or when the dose is changed. [read more] Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

You should not take Qelbree if you or your child:
Take a medicine for depression called a monoamine oxidase inhibitor (MAOI) or have stopped taking an MAOI in the past 14 days. Also, you or your child should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.

Qelbree can increase blood pressure and heart rate. Your or your child’s doctor will monitor these vital signs.

Qelbree may cause manic episodes in patients with bipolar disorder. Tell your doctor if you or your child show any signs of mania.

Do not drive or operate heavy machinery until you know how Qelbree will affect you or your child. Qelbree may cause you or your child to feel sleepy or tired.

The most common side effects of Qelbree in patients 6 to 17 years are sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability, and in adults, insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation. These are not all the possible side effects of Qelbree.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Medication Guide including Boxed Warning.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE

INDICATION

Qelbree® (viloxazine extended-release capsules) is a prescription medicine used to treat ADHD in adults and children 6 years and older.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment [read more] or when the dose is changed. Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment or when the dose is changed. [read more] Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

You should not take Qelbree if you or your child:
Take a medicine for depression called a monoamine oxidase inhibitor (MAOI) or have stopped taking an MAOI in the past 14 days. Also, you or your child should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.

Qelbree can increase blood pressure and heart rate. Your or your child’s doctor will monitor these vital signs.

Qelbree may cause manic episodes in patients with bipolar disorder. Tell your doctor if you or your child show any signs of mania.

Do not drive or operate heavy machinery until you know how Qelbree will affect you or your child. Qelbree may cause you or your child to feel sleepy or tired.

The most common side effects of Qelbree in patients 6 to 17 years are sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability, and in adults, insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation. These are not all the possible side effects of Qelbree.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Medication Guide including Boxed Warning.